Table 3.
Multivariate analysis for 5-year bDFS.
| HR (95% CI) | p | p value** | |
|---|---|---|---|
| PSA | |||
| ≥0.02 vs. <0.02 | 2.67 (1.04–6.83) | 0.03 | 0.03 | 
| Risk class17 | |||
| Intermediate vs. low risk | 1.70 (0.82–3.52) | 0.15 | 0.36 | 
| High vs. low risk | 1.49 (0.69–3.22) | 0.30 | |
| Pathological Gleason score | |||
| GL 7 vs. GL 3–6 | 2.89 (0.99–8.42) | 0.05 | 0.05 | 
| GL 8–10 vs. GL 3–6 | 3.79 (1.28–11.16) | 0.05 | |
| Pathological nodal status | |||
| pN1 vs. pN0 | 1.14 (0.51–2.55) | 0.74 | 0.17 | 
| pNx vs. pN0 | 0.53 (0.26–1.07) | 0.07 | |
| Surgical margins status | |||
| Positive vs. negative | 1.81 (0.96–3.41) | 0.06 | 0.06 | 
| Adjuvant hormonal therapy | |||
| Yes vs. no | 1.54 (0.87–2.72) | 0.13 | 0.13 | 
Wald chi-square statistic.